_id
691301fdccc777a4e85d796d
Ticker
INMB
Name
INmune Bio Inc
Exchange
NASDAQ
Address
225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.inmunebio.com
Description
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Last Close
2.14
Volume
349944
Current Price
2.01
Change
-6.074766355140202
Last Updated
2025-12-01T09:21:33.384Z
Image
-
Ipo Date
2019-02-04T00:00:00.000Z
Market Cap
46258348
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5705
Sentiment Sources
2
Rating
4.4
Target Price
5.25
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
28000
Gross Profit
-28000
Operating Expenses
7405000
Operating Income
-7433000
Interest Expense
-
Pretax Income
-6472000
Net Income
-6472000
Eps
-0.2434431894548475
Dividends Per Share
-
Shares Outstanding
26585258
Income Tax Expense
-
EBITDA
-6444000
Operating Margin
-
Total Other Income Expense Net
961000
Cash
27734000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
30670000
Property Plant Equipment
1064000
Total Assets
33358000
Payables
6900000
Short Term Debt
457000
Long Term Debt
-
Total Liabilities
7980000
Equity
25378000
Depreciation
28000
Change In Working Capital
-1353000
Cash From Operations
-5439000
Capital Expenditures
193000
Cash From Investing
-193000
Cash From Financing
0
Net Change In Cash
-5640000
PE
-
PB
2.1056178020332568
ROE
-25.502403656710538
ROA
-19.40164278433959
FCF
-5632000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
28000
Quarters > 0 > income Statement > gross Profit
-28000
Quarters > 0 > income Statement > operating Expenses
7405000
Quarters > 0 > income Statement > operating Income
-7433000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-6472000
Quarters > 0 > income Statement > net Income
-6472000
Quarters > 0 > income Statement > eps
-0.2434431894548475
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26585258
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6444000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
961000
Quarters > 0 > balance Sheet > cash
27734000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
30670000
Quarters > 0 > balance Sheet > property Plant Equipment
1064000
Quarters > 0 > balance Sheet > total Assets
33358000
Quarters > 0 > balance Sheet > payables
6900000
Quarters > 0 > balance Sheet > short Term Debt
457000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7980000
Quarters > 0 > balance Sheet > equity
25378000
Quarters > 0 > cash Flow > net Income
-6472000
Quarters > 0 > cash Flow > depreciation
28000
Quarters > 0 > cash Flow > change In Working Capital
-1353000
Quarters > 0 > cash Flow > cash From Operations
-5439000
Quarters > 0 > cash Flow > capital Expenditures
193000
Quarters > 0 > cash Flow > cash From Investing
-193000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-5640000
Quarters > 0 > ratios > PE
-0.2434431894548475
Quarters > 0 > ratios > PB
2.1056178020332568
Quarters > 0 > ratios > ROE
-25.502403656710538
Quarters > 0 > ratios > ROA
-19.40164278433959
Quarters > 0 > ratios > FCF
-5632000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
24571000
Quarters > 1 > income Statement > operating Income
-24571000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-24458000
Quarters > 1 > income Statement > net Income
-24458000
Quarters > 1 > income Statement > eps
-1.0497691799735218
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
23298455
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-8057000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
113000
Quarters > 1 > balance Sheet > cash
33374000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2155000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
36034000
Quarters > 1 > balance Sheet > property Plant Equipment
1080000
Quarters > 1 > balance Sheet > total Assets
37684000
Quarters > 1 > balance Sheet > payables
7855000
Quarters > 1 > balance Sheet > short Term Debt
220000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8817000
Quarters > 1 > balance Sheet > equity
28867000
Quarters > 1 > cash Flow > net Income
-24458000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-965000
Quarters > 1 > cash Flow > cash From Operations
-7375000
Quarters > 1 > cash Flow > capital Expenditures
705999
Quarters > 1 > cash Flow > cash From Investing
-706000
Quarters > 1 > cash Flow > cash From Financing
22271000
Quarters > 1 > cash Flow > net Change In Cash
14037000
Quarters > 1 > ratios > PE
-1.0497691799735218
Quarters > 1 > ratios > PB
1.6222639882911283
Quarters > 1 > ratios > ROE
-84.72650431288322
Quarters > 1 > ratios > ROA
-64.90287655238298
Quarters > 1 > ratios > FCF
-8080999
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
50000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
50000
Quarters > 2 > income Statement > operating Expenses
9955000
Quarters > 2 > income Statement > operating Income
-9905000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-9739000
Quarters > 2 > income Statement > net Income
-9739000
Quarters > 2 > income Statement > eps
-0.43292140825035563
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
22496000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-9905000
Quarters > 2 > income Statement > operating Margin
-19810
Quarters > 2 > income Statement > total Other Income Expense Net
166000
Quarters > 2 > balance Sheet > cash
19337000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1416000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
20960000
Quarters > 2 > balance Sheet > property Plant Equipment
278000
Quarters > 2 > balance Sheet > total Assets
37801000
Quarters > 2 > balance Sheet > payables
7301000
Quarters > 2 > balance Sheet > short Term Debt
146000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8128000
Quarters > 2 > balance Sheet > equity
29673000
Quarters > 2 > cash Flow > net Income
-9739000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
839000
Quarters > 2 > cash Flow > cash From Operations
-6824000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
5274000
Quarters > 2 > cash Flow > net Change In Cash
-1585000
Quarters > 2 > ratios > PE
-0.43292140825035563
Quarters > 2 > ratios > PB
1.5238418764533412
Quarters > 2 > ratios > ROE
-32.821083139554474
Quarters > 2 > ratios > ROA
-25.763868680722734
Quarters > 2 > ratios > FCF
-6824000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-136.48
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
9467000
Quarters > 3 > income Statement > operating Income
-9467000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9218000
Quarters > 3 > income Statement > net Income
-9218000
Quarters > 3 > income Statement > eps
-0.4137342908438061
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
22280000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-9218000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
249000
Quarters > 3 > balance Sheet > cash
20922000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1409000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
22662000
Quarters > 3 > balance Sheet > property Plant Equipment
307000
Quarters > 3 > balance Sheet > total Assets
39562000
Quarters > 3 > balance Sheet > payables
6564000
Quarters > 3 > balance Sheet > short Term Debt
140000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7465000
Quarters > 3 > balance Sheet > equity
32097000
Quarters > 3 > cash Flow > net Income
-9218000
Quarters > 3 > cash Flow > depreciation
9467000
Quarters > 3 > cash Flow > change In Working Capital
-3558000
Quarters > 3 > cash Flow > cash From Operations
-11013000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-2078000
Quarters > 3 > cash Flow > net Change In Cash
-12630000
Quarters > 3 > ratios > PE
-0.4137342908438061
Quarters > 3 > ratios > PB
1.3952331993644265
Quarters > 3 > ratios > ROE
-28.7191949403371
Quarters > 3 > ratios > ROA
-23.300136494616044
Quarters > 3 > ratios > FCF
-11013000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
14000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
14000
Annuals > 0 > income Statement > operating Expenses
42649000
Annuals > 0 > income Statement > operating Income
-42635000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-42082000
Annuals > 0 > income Statement > net Income
-42082000
Annuals > 0 > income Statement > eps
-2.110008022462896
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
19944000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-42082000
Annuals > 0 > income Statement > operating Margin
-304535.71428571426
Annuals > 0 > income Statement > total Other Income Expense Net
553000
Annuals > 0 > balance Sheet > cash
20922000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1409000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
22662000
Annuals > 0 > balance Sheet > property Plant Equipment
307000
Annuals > 0 > balance Sheet > total Assets
39562000
Annuals > 0 > balance Sheet > payables
6564000
Annuals > 0 > balance Sheet > short Term Debt
140000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7465000
Annuals > 0 > balance Sheet > equity
32097000
Annuals > 0 > cash Flow > net Income
-42082000
Annuals > 0 > cash Flow > depreciation
553000
Annuals > 0 > cash Flow > change In Working Capital
1037000
Annuals > 0 > cash Flow > cash From Operations
-33361000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
18211000
Annuals > 0 > cash Flow > net Change In Cash
-14926000
Annuals > 0 > ratios > PE
-2.110008022462896
Annuals > 0 > ratios > PB
1.081177680157024
Annuals > 0 > ratios > ROE
-131.10882637006574
Annuals > 0 > ratios > ROA
-106.36974874879934
Annuals > 0 > ratios > FCF
-33361000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2382.9285714285716
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
155000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
155000
Annuals > 1 > income Statement > operating Expenses
29896000
Annuals > 1 > income Statement > operating Income
-29741000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-30008000
Annuals > 1 > income Statement > net Income
-30008000
Annuals > 1 > income Statement > eps
-1.6688726989600133
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
17981000
Annuals > 1 > income Statement > income Tax Expense
-29741000
Annuals > 1 > income Statement > EBITDA
-29741000
Annuals > 1 > income Statement > operating Margin
-19187.74193548387
Annuals > 1 > income Statement > total Other Income Expense Net
-267000
Annuals > 1 > balance Sheet > cash
35848000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2442000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
39942000
Annuals > 1 > balance Sheet > property Plant Equipment
414000
Annuals > 1 > balance Sheet > total Assets
57001000
Annuals > 1 > balance Sheet > payables
7901000
Annuals > 1 > balance Sheet > short Term Debt
10040000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
18862000
Annuals > 1 > balance Sheet > equity
38139000
Annuals > 1 > cash Flow > net Income
-30008000
Annuals > 1 > cash Flow > depreciation
224000
Annuals > 1 > cash Flow > change In Working Capital
10436000
Annuals > 1 > cash Flow > cash From Operations
-11980000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-4225000
Annuals > 1 > cash Flow > net Change In Cash
-16305000
Annuals > 1 > ratios > PE
-1.6688726989600133
Annuals > 1 > ratios > PB
0.8203398096436718
Annuals > 1 > ratios > ROE
-78.68061564278037
Annuals > 1 > ratios > ROA
-52.6446904440273
Annuals > 1 > ratios > FCF
-11980000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-77.29032258064517
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
374000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
374000
Annuals > 2 > income Statement > operating Expenses
26325000
Annuals > 2 > income Statement > operating Income
-25951000
Annuals > 2 > income Statement > interest Expense
1348000
Annuals > 2 > income Statement > pretax Income
-27299000
Annuals > 2 > income Statement > net Income
-28647000
Annuals > 2 > income Statement > eps
-1.5979806995035422
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
17927000
Annuals > 2 > income Statement > income Tax Expense
1348000
Annuals > 2 > income Statement > EBITDA
-27299000
Annuals > 2 > income Statement > operating Margin
-6938.770053475936
Annuals > 2 > income Statement > total Other Income Expense Net
-1348000
Annuals > 2 > balance Sheet > cash
52153000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
8461000
Annuals > 2 > balance Sheet > inventories
34000
Annuals > 2 > balance Sheet > total Current Assets
64675000
Annuals > 2 > balance Sheet > property Plant Equipment
507000
Annuals > 2 > balance Sheet > total Assets
81795000
Annuals > 2 > balance Sheet > payables
5206000
Annuals > 2 > balance Sheet > short Term Debt
5087000
Annuals > 2 > balance Sheet > long Term Debt
9697000
Annuals > 2 > balance Sheet > total Liabilities
21691000
Annuals > 2 > balance Sheet > equity
60104000
Annuals > 2 > cash Flow > net Income
-27299000
Annuals > 2 > cash Flow > depreciation
239000
Annuals > 2 > cash Flow > change In Working Capital
-2864000
Annuals > 2 > cash Flow > cash From Operations
-22686000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
729000
Annuals > 2 > cash Flow > net Change In Cash
-22657000
Annuals > 2 > ratios > PE
-1.5979806995035422
Annuals > 2 > ratios > PB
0.5189834287235459
Annuals > 2 > ratios > ROE
-47.662385198988424
Annuals > 2 > ratios > ROA
-35.02292316156244
Annuals > 2 > ratios > FCF
-22686000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-60.657754010695186
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
181000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
181000
Annuals > 3 > income Statement > operating Expenses
29334000
Annuals > 3 > income Statement > operating Income
-29153000
Annuals > 3 > income Statement > interest Expense
1187000
Annuals > 3 > income Statement > pretax Income
-30340000
Annuals > 3 > income Statement > net Income
-30340000
Annuals > 3 > income Statement > eps
-1.8808505362345793
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
16131000
Annuals > 3 > income Statement > income Tax Expense
1187000
Annuals > 3 > income Statement > EBITDA
-30340000
Annuals > 3 > income Statement > operating Margin
-16106.629834254145
Annuals > 3 > income Statement > total Other Income Expense Net
-1187000
Annuals > 3 > balance Sheet > cash
74810000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
5504000
Annuals > 3 > balance Sheet > inventories
-5504000
Annuals > 3 > balance Sheet > total Current Assets
82606000
Annuals > 3 > balance Sheet > property Plant Equipment
726000
Annuals > 3 > balance Sheet > total Assets
99945000
Annuals > 3 > balance Sheet > payables
3803000
Annuals > 3 > balance Sheet > short Term Debt
144000
Annuals > 3 > balance Sheet > long Term Debt
14458000
Annuals > 3 > balance Sheet > total Liabilities
19720000
Annuals > 3 > balance Sheet > equity
80225000
Annuals > 3 > cash Flow > net Income
-30340000
Annuals > 3 > cash Flow > depreciation
126000
Annuals > 3 > cash Flow > change In Working Capital
-3086000
Annuals > 3 > cash Flow > cash From Operations
-28504000
Annuals > 3 > cash Flow > capital Expenditures
15000000
Annuals > 3 > cash Flow > cash From Investing
-15000000
Annuals > 3 > cash Flow > cash From Financing
96357000
Annuals > 3 > cash Flow > net Change In Cash
52843000
Annuals > 3 > ratios > PE
-1.8808505362345793
Annuals > 3 > ratios > PB
0.34986525397320034
Annuals > 3 > ratios > ROE
-37.81863508881271
Annuals > 3 > ratios > ROA
-30.356696182900595
Annuals > 3 > ratios > FCF
-43504000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-240.353591160221
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2434431894548475
Valuation > metrics > PB
2.1056178020332568
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-25.502403656710538
Profitability > metrics > ROA
-21.102054124551678
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3144455827882418
Risk > metrics > Interest Coverage
-265.4642857142857
Risk > final Score
-1002
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.168818812015767
Liquidity > metrics > Quick Ratio
4.168818812015767
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
54
Prev Risks > 1
-179
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:40:27.193Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.24
Earnings History > 0 > eps Estimate
-0.325
Earnings History > 0 > eps Difference
0.085
Earnings History > 0 > surprise Percent
26.1538
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.341
Earnings History > 1 > eps Estimate
-0.4267
Earnings History > 1 > eps Difference
0.0857
Earnings History > 1 > surprise Percent
20.0844
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.43
Earnings History > 2 > eps Estimate
-0.49
Earnings History > 2 > eps Difference
0.06
Earnings History > 2 > surprise Percent
12.2449
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.4
Earnings History > 3 > eps Estimate
-0.54
Earnings History > 3 > eps Difference
0.14
Earnings History > 3 > surprise Percent
25.9259
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-31
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.6
Earnings History > 4 > eps Estimate
-0.5
Earnings History > 4 > eps Difference
-0.1
Earnings History > 4 > surprise Percent
-20
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.5
Earnings History > 5 > eps Estimate
-0.63
Earnings History > 5 > eps Difference
0.13
Earnings History > 5 > surprise Percent
20.6349
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.61
Earnings History > 6 > eps Estimate
-0.53
Earnings History > 6 > eps Difference
-0.08
Earnings History > 6 > surprise Percent
-15.0943
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.47
Earnings History > 7 > eps Estimate
-0.44
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-6.8182
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-01
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.48
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
-0.09
Earnings History > 8 > surprise Percent
-23.0769
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-07
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.36
Earnings History > 9 > eps Estimate
-0.4
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
10
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-03
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
-0.02
Earnings History > 10 > eps Difference
-0.34
Earnings History > 10 > surprise Percent
-1700
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-02
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.32
Earnings History > 11 > eps Estimate
-0.48
Earnings History > 11 > eps Difference
0.16
Earnings History > 11 > surprise Percent
33.3333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-02
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.43
Earnings History > 12 > eps Estimate
-0.52
Earnings History > 12 > eps Difference
0.09
Earnings History > 12 > surprise Percent
17.3077
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-03
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.38
Earnings History > 13 > eps Estimate
-0.5
Earnings History > 13 > eps Difference
0.12
Earnings History > 13 > surprise Percent
24
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.39
Earnings History > 14 > eps Estimate
-0.64
Earnings History > 14 > eps Difference
0.25
Earnings History > 14 > surprise Percent
39.0625
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.55
Earnings History > 15 > eps Estimate
-0.58
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
5.1724
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-03
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.55
Earnings History > 16 > eps Estimate
-0.35
Earnings History > 16 > eps Difference
-0.2
Earnings History > 16 > surprise Percent
-57.1429
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.44
Earnings History > 17 > eps Estimate
-0.34
Earnings History > 17 > eps Difference
-0.1
Earnings History > 17 > surprise Percent
-29.4118
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-05
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.32
Earnings History > 18 > eps Estimate
-0.27
Earnings History > 18 > eps Difference
-0.05
Earnings History > 18 > surprise Percent
-18.5185
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.26
Earnings History > 19 > eps Estimate
-0.31
Earnings History > 19 > eps Difference
0.05
Earnings History > 19 > surprise Percent
16.129
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.36
Earnings History > 20 > eps Estimate
-0.17
Earnings History > 20 > eps Difference
-0.19
Earnings History > 20 > surprise Percent
-111.7647
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-05
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.2
Earnings History > 21 > eps Estimate
-0.2
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.19
Earnings History > 22 > eps Estimate
-0.21
Earnings History > 22 > eps Difference
0.02
Earnings History > 22 > surprise Percent
9.5238
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-11
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.22
Earnings History > 23 > eps Estimate
-0.25
Earnings History > 23 > eps Difference
0.03
Earnings History > 23 > surprise Percent
12
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-08
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.28
Earnings History > 24 > eps Estimate
-0.19
Earnings History > 24 > eps Difference
-0.09
Earnings History > 24 > surprise Percent
-47.3684
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-09
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.19
Earnings History > 25 > eps Estimate
-0.19
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
0
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-15
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.2
Earnings History > 26 > eps Estimate
-0.19
Earnings History > 26 > eps Difference
-0.01
Earnings History > 26 > surprise Percent
-5.2632
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-29
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.21
Earnings History > 27 > eps Estimate
-0.19
Earnings History > 27 > eps Difference
-0.02
Earnings History > 27 > surprise Percent
-10.5263
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-21
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.04
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.04
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.55
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.55
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-06-13
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.25
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.25
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-09-30
Earnings History > 31 > report Date
2017-12-01
Earnings History > 31 > date
2017-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.03
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.03
Earnings History > 31 > surprise Percent
-
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AINmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen Defense World
Read more →INmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$5.25
Analyst Picks
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 24.72% of the total shares of INmune Bio Inc
1.
BlackRock Inc(4.4101%)
since
2025/06/30
2.
Vanguard Group Inc(3.1888%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.8019%)
since
2025/07/31
4.
UBS Group AG(1.6897%)
since
2025/06/30
5.
iShares Russell 2000 ETF(1.5295%)
since
2025/08/31
6.
Geode Capital Management, LLC(1.4667%)
since
2025/06/30
7.
State Street Corp(1.0359%)
since
2025/06/30
8.
Dauntless Investment Group, LLC(0.9349%)
since
2025/06/30
9.
Rhenman Partners Asset Management AB(0.6706%)
since
2025/06/30
10.
Rhenman Healthcare Equity L/S RC2 SEK(0.6706%)
since
2025/05/31
11.
Fidelity Small Cap Index(0.6349%)
since
2025/06/30
12.
Northern Trust Corp(0.6185%)
since
2025/06/30
13.
Vanguard Institutional Extnd Mkt Idx Tr(0.5667%)
since
2025/07/31
14.
iShares Russell 2000 Growth ETF(0.5486%)
since
2025/08/31
15.
XTX Topco Ltd(0.4734%)
since
2025/06/30
16.
Morgan Stanley - Brokerage Accounts(0.3864%)
since
2025/06/30
17.
Fidelity Extended Market Index(0.3172%)
since
2025/07/31
18.
Vanguard Russell 2000 ETF(0.2967%)
since
2025/07/31
19.
JPMorgan Chase & Co(0.275%)
since
2025/06/30
20.
SIMPLEX TRADING, LLC(0.2646%)
since
2025/06/30
21.
Bank of New York Mellon Corp(0.2317%)
since
2025/06/30
22.
Charles Schwab Investment Management Inc(0.1949%)
since
2025/06/30
23.
Buckingham Strategic Partners(0.1836%)
since
2025/06/30
24.
Royal Bank of Canada(0.1835%)
since
2025/06/30
25.
Mccormack Advisors International(0.1814%)
since
2025/06/30
26.
Scientech Research LLC(0.172%)
since
2025/06/30
27.
LPL Financial Corp(0.1624%)
since
2025/06/30
28.
Millennium Management LLC(0.1603%)
since
2025/06/30
29.
State St Russell Sm Cap® Indx SL Cl I(0.1576%)
since
2025/08/31
30.
Schwab Small Cap Index(0.1573%)
since
2025/07/31
31.
NT R2000 Index Fund - NL(0.1518%)
since
2025/06/30
32.
Extended Equity Market Fund K(0.1425%)
since
2025/06/30
33.
iShares Micro-Cap ETF(0.1399%)
since
2025/08/31
34.
SPDR® Russell 2000 US Small Cap ETF(0.1254%)
since
2025/08/31
35.
NT R2000 Index Fund - DC - NL - 3(0.1211%)
since
2025/06/30
36.
Russell 2500™ Index Fund F(0.1169%)
since
2025/06/30
37.
Fidelity Total Market Index(0.1105%)
since
2025/07/31
38.
iShares Russell 2000 Small-Cap Idx Instl(0.0916%)
since
2025/07/31
39.
Fidelity Series Total Market Index(0.0813%)
since
2025/07/31
40.
Russell 2000 Index Non-Lendable Fund E(0.077%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.24
EPS Estimate
-0.325
EPS Difference
0.085
Surprise Percent
26.1538%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.